Status:
COMPLETED
Exercise and Cognitive-psychosocial Functions in Men With Prostate Cancer Receiving Androgen Depletion Therapy
Lead Sponsor:
University of Manitoba
Collaborating Sponsors:
Health Sciences Centre Foundation, Manitoba
Conditions:
Prostate Cancer
Eligibility:
MALE
50+ years
Phase:
NA
Brief Summary
The objective of the proposed research is to determine the efficacy of a home-based walking exercise program in promoting cognitive-psychosocial functions of men with prostate cancer receiving androge...
Eligibility Criteria
Inclusion
- men aged 50 or older
- diagnosed with adenocarcinoma prostate cancer
- will initiate and receive continuous ADT (LHRH or combination of LHRH and anti-androgen for at least 6 months
Exclusion
- severe cardiac disease (New York Heart Association class III or greater)
- angina
- severe osteoporosis
- uncontrolled hypertension
- orthostastic blood pressure drop \> 20mm Hg
- moderate to severe aortic stenosis
- acute illness or fever
- uncontrolled atrial or ventricular dysrhythmias
- uncontrolled sinus tachycardia (\> 120 beats per minute)
- uncontrolled congestive heart failure
- third-degree atrio-ventricular heart block
- active pericarditis or myocarditis
- recent embolism, thrombophlebitis
- deep vein thrombosis, resting ST displacement
- uncontrolled diabetes
- uncontrolled pain
- cognitive impairment
- history of falls due to balance impairment or lost of consciousness
- severe neuromusculoskeletal conditions that limit their ability to perform walking exercise
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00856102
Start Date
March 1 2009
End Date
December 1 2010
Last Update
February 1 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Manitoba
Winnipeg, Manitoba, Canada, R3E 0T6